Companies: 10,795·Total market cap: $144.5T
Exelixis, Inc.

Exelixis, Inc.

EXELNASDAQHealthcare● Active
$52.70
+$0.21(+0.40%)
Market Cap$13.2B
P/E Ratio
52W High$52.98
52W Low$33.76

Exelixis, Inc.(EXEL)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EXEL · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2026-012025-012023-122022-122021-12
Revenue
Revenue$2.32B$2.17B$1.83B$1.61B$1.43B
Cost of Revenue$0.08B$0.08B$0.07B$0.06B$0.05B
Gross Profit$2.24B$2.09B$1.76B$1.55B$1.38B
Gross Margin %(computed)96.39%96.49%96.04%96.41%96.32%
Operating Expenses
R&D Expenses$0.83B$0.91B$1.04B$0.89B$0.69B
G&A Expenses$0.47B$0.49B$0.54B$0.42B$0.37B
Total Operating Expenses$1.36B$1.49B$1.59B$1.35B$1.10B
Operating Income$0.87B$0.60B$0.17B$0.20B$0.29B
Operating Margin %(computed)37.59%27.88%9.34%12.51%19.98%
Interest Income$0.07B$0.08B$0.09B$0.03B$0.01B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.94B$0.68B$0.26B$0.23B$0.29B
Income Tax Expense$0.16B$0.16B$0.05B$0.05B$0.06B
Net Income$0.78B$0.52B$0.21B$0.18B$0.23B
Net Margin %(computed)33.73%24.04%11.35%11.31%16.10%
Per Share & EBITDA
EPS (Basic)$2.88$1.80$0.65$0.57$0.73
Wtd Avg Shares0.27B0.29B0.32B0.32B0.31B
EBITDA$0.92B$0.72B$0.20B$0.22B$0.30B
EBITDA Margin %(computed)39.73%33.14%10.74%13.80%20.93%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Exelixis, Inc.

关于Exelixis, Inc.(EXEL)损益表

Exelixis, Inc.(EXEL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,EXEL实现营收$2.32B,毛利润$2.24B(毛利率96.39%),净利润$0.78B(净利率33.73%)。

常见问题

EXEL · 4 问

Exelixis, Inc.(EXEL)2026财年营收为$2.32B,同比up7.0%。

EXEL revenueEXEL salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08